Is this you? Create Your Porfile
Avatar

Douglas Edward Prather

Eli Lilly and Company

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Douglas Edward Prather is active.

Explore More

Publication

Featured researches published by Douglas Edward Prather.

Journal of Organic Chemistry | 1991

Synthesis of 2,3-O-isopropylidene-D-glyceraldehyde in high chemical and optical purity: observations on the development of a practical bulk process

Christopher R. Schmid; Jerry D. Bryant; Joseph L. Phillips; Douglas Edward Prather; Renee D. Schantz; Nancy L. Sear; Catherine S. Vianco

Archive | 1994

Preparation of 3,4,4-trisubstituted piperidinyl-n-alkylcarboxylates and intermediates

Scott Alan Frank; Douglas Edward Prather; Jeffrey A. Ward; John Arnold Werner

Archive | 1994

Preparation of 3,4,4-trisubstitutedpiperidinyl-n-alkylcarboxylates and intermediates, useful as opioid antagonists

Scott Alan Frank; Douglas Edward Prather; Jeffrey A. Ward; John Arnold Werner

Archive | 1994

Trisubstituted-piperidinyl-N-alkylcarboxylates as opioid antagonists

Scott Alan Frank; Douglas Edward Prather; Jeffrey A. Ward; John Arnold Werner

Archive | 1994

Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof

Jane Goedde Amos; Perry Clark Heath; Douglas Edward Prather; John E. Toth

Archive | 2000

Process for preparing a crystalline dihydrate, and the crystalline intermediate

Douglas Edward Prather; Scott Alan Frank; Jeffrey A. Ward; John Arnold Werner

Archive | 1994

Loracarbef Hydrochlorid C1-C3 Alkohol-Solvate und deren Verwendungen Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof

Jane Goedde Amos; Perry Clark Heath; Douglas Edward Prather; John E. Toth

Archive | 1994

Pipéridinyl-N-alkylcarboxylates trisubstituées en tant qu'opioid antagonistes

Scott Alan Frank; Douglas Edward Prather; Jeffrey A. Ward; John Arnold Werner

Archive | 1994

Herstellung von 3,4,4-trisubstituiertem Piperidinyl-n-alkylcarboxylaten und Zwischenverbindungen, verwendbar als opioid Antagonisten

Scott Alan Frank; Douglas Edward Prather; Jeffrey A. Ward; John Arnold Werner

Archive | 1994

3,4,4-Trisubstituierte Piperidinderivate und ihre Verwendung als Opioid Antagonisten

Scott Alan Frank; Douglas Edward Prather; John Arnold Werner

Explore More

Collaboration

Dive into the Douglas Edward Prather's collaboration.

Top Co-Authors
Avatar

John Arnold Werner

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Scott Alan Frank

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Jeffrey A. Ward

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Jane Goedde Amos

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

John E. Toth

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Perry Clark Heath

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Catherine S. Vianco

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Christopher R. Schmid

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Jerry D. Bryant

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Joseph L. Phillips

Eli Lilly and Company

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge